Lloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
Lloyd Inc is recalling 19,166 bottles of Levothroid 50 mcg tablets because they failed potency testing at 9 months.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a Moderate severity score when no specific hospitalizations or severe injuries are reported in the source text.
Plain-English summary
Lloyd Inc is recalling 19,166 bottles of Levothroid (levothyroxine sodium tablets, USP), 50 mcg, packaged in 100-count bottles. The product is identified by NDC 0456-1321-01 and Lot 1087589. The recall was initiated because the tablets were found to be subpotent, meaning they had a low assay result at the 9-month test interval.
The affected product was distributed nationwide and in Puerto Rico. Levothroid is a prescription medication manufactured for Forest Pharmaceuticals, Inc., a subsidiary of Forest Laboratories, Inc., by Lloyd Pharmaceutical in Shenandoah, Iowa.
Consumers with this specific lot of Levothroid should contact their healthcare provider or pharmacist for guidance on obtaining a replacement or alternative treatment. The recall is classified as Class II by the FDA, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Levothroid (levothyroxine sodium tablets, USP), 50 mcg., packaged in 100-ct. bottles, RX, NDC 0456-1321-01. Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
- Manufacturer
- Lloyd Inc
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 19,166
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 1087589
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Lloyd Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Lloyd Inc
See all →- ModerateLloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
FDA (Drugs) · 2012-07-04
- ModerateLloyd Inc Recalls Subpotent Thyro-Tab 0.050mg Bulk Tablets
FDA (Drugs) · 2012-07-04
- SevereLloyd Inc Recalls Subpotent Thyro-Tab 0.75 mg Tablets
FDA (Drugs) · 2012-07-04
Same hazard · subpotent drug
See all →- LowImprimisRx Recalls Subpotent Povidone Iodine and Proparacaine Ophthalmic Solution
FDA (Drugs) · 2026-09-16
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets
FDA (Drugs) · 2026-09-02
Similar recalls
- ModerateLloyd Inc Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
FDA (Drugs) · 2012-07-04
- SevereLloyd Inc. of Iowa Recalls Subpotent Levothroid Levothyroxine Sodium Tablets
FDA (Drugs) · 2013-01-02
- ModerateLloyd Inc. of Iowa Recalls Subpotent Levothroid 75 mcg Tablets
FDA (Drugs) · 2013-01-02
- SevereLloyd Inc. Recalls Levothroid Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2012-12-12
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to cGMP Deviations
FDA (Drugs) · 2012-12-12